Epoch Biodesign raises $12 million to scale AI-driven nylon recycling
London-based Epoch Biodesign has raised $12 million to prove that its AI-designed enzymes can recycle nylon 6,6 at industrial scale. The company says it recovers more than 90% of the original monomers from waste ranging from sportswear to carpets and airbags, without needing new petroleum-based feedstock. Total funding raised has now passed $50 million.
AI-processed from TNW; edited by Hamidun News
Epoch Biodesign has raised $12 million to prove that its AI-designed enzymes can be used for industrial-scale recycling of nylon 6,6. For the market, this is not just another climate startup, but an attempt to turn one of the hardest plastic waste streams into reusable feedstock without new oil.
How the technology works
The London company develops enzymes that break nylon 6,6 waste back down into its original monomers. The material shows up in a wide range of products, from leggings and sportswear to carpets and automotive airbags. In the conventional chain, this plastic is usually either burned or sent to low-grade recycling.
Epoch Biodesign's approach aims at a higher-value route: returning the material to nearly its original chemical state so it can be made into new nylon again. The key idea is not to downcycle waste but to restore its chemical value.
According to the company, the process recovers more than 90% of the original feedstock. That figure matters because recycling economics depend not only on environmental benefit but also on usable yield. If the technology holds that level not in a lab test tube but on a large feedstock stream, it could reduce demand for virgin petrochemical raw materials. That makes the project interesting not only for the climate agenda but also for materials producers looking to stabilize supply and reduce exposure to commodity market swings.
Why the round matters
The new $12 million round is meant to show that the technology works not only as a scientific demonstration but as a scalable industrial process. In biotech and climate tech, this is the hardest stage. A good result at small volume does not mean the enzymes will work as efficiently on the contaminated, heterogeneous and logistically expensive waste that comes from the real market.
Based on the stated purpose of the round, Epoch Biodesign has to tackle several tasks at once:
- confirm stable monomer yield at large volumes;
- adapt the process to different types of nylon 6,6 waste;
- show economics that do not rely on virgin feedstock;
- lay the groundwork for working with industrial partners.
Total capital raised has now passed $50 million, which suggests investors see the technology not as a niche story but as a potential platform for a whole class of materials.
Nylon 6,6 has long been considered one of the most useful synthetic materials: it is strong, heat-resistant and widely used in textiles and industry. But precisely because it is so useful, it has accumulated in enormous quantities, and recycling it well remains difficult.
If Epoch Biodesign can prove industrial efficiency, the company will land at an important point in the market where AI, bioengineering and the circular economy meet. Here AI is not an interface or a chatbot but a tool for designing molecular systems with a concrete economic effect. For the industry, this is a notable signal: the next big AI use case may come not from software but from production chains, where algorithms help create new processes, materials and ways of disposal. If the model works, similar approaches will start being tested on other hard-to-recycle polymers.
What this means
For the AI market, this news matters because it shows a more mature use case for artificial intelligence: not content generation, but the creation of enzymes with a measurable industrial result. If Epoch Biodesign confirms scalability, it will boost interest in startups that use AI for chemistry, materials science and recycling, where value is determined not by demos but by yield, cost and process stability.
Key Questions Answered
How the technology works?
The London company develops enzymes that break nylon 6,6 waste back down into its original monomers. The material shows up in a wide range of products, from leggings and sportswear to carpets and automotive airbags. In the conventional chain, this plastic is usually either burned or sent to low-grade recycling. Epoch Biodesign's approach aims at a higher-value route: returning the material to nearly its original chemical state so it can be made into new nylon again. The key idea is not to downcycle waste but to restore its chemical value. According to the company, the proce
Why the round matters?
The new $12 million round is meant to show that the technology works not only as a scientific demonstration but as a scalable industrial process. In biotech and climate tech, this is the hardest stage. A good result at small volume does not mean the enzymes will work as efficiently on the contaminated, heterogeneous and logistically expensive waste that comes from the real market. Based on the stated purpose of the round, Epoch Biodesign has to tackle several tasks at once: confirm stable monomer yield at large volumes; adapt the process to different types of nylon 6,6 wast
What this means?
For the AI market, this news matters because it shows a more mature use case for artificial intelligence: not content generation, but the creation of enzymes with a measurable industrial result. If Epoch Biodesign confirms scalability, it will boost interest in startups that use AI for chemistry, materials science and recycling, where value is determined not by demos but by yield, cost and process stability.
Ship AI Faster with Founders, Engineers & Weekly Architecture Reviews
Inside Vibe Club (hamidun.com/club) — weekly live masterminds with Zhemal Khamidun, Tech Radar, full LMS access, and 370+ production Claude Code skills.
The AI world, distilled — once a week
Seven stories that actually mattered, hand-picked. No noise, no reposts, no press releases.
Done! Check your inbox for a confirmation.